Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

R1 Announces New Patient Experience Solution for the Revenue Cycle

Posted on: 05 Mar 18

CHICAGO, March 05, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced the availability of its new Patient Experience (PX) platform. Built on fifteen years of experience, the R1 PX solution now offers intuitive digital self-service capabilities that simplify and reinvent the patient experience, while simultaneously improving business outcomes for health systems.

Maintaining a strong revenue cycle and delivering both great patient experience and seamless clinical workflow are often at odds. Too often, the healthcare experience for patients is confusing and inconvenient. Current technologies are fragmented, limited in functionality, and not modernized to meet patients’ expectations, making it difficult for providers to offer a seamless, intuitive experience while also protecting revenue.

With the R1 PX platform, health systems can transform the patient experience, ease physician administrative burden, and drive overall operational efficiencies—all while improving healthcare provider business performance. Concurrently, patients are able to manage their data in one easy-to-use environment, retain key administrative information on-file and access the platform from their own mobile devices at home or on devices like kiosks and tablets conveniently placed at physician offices and hospitals. In addition, the R1 PX solution provides concierge-like support at sites of care for those patients requiring additional assistance.

In the initial R1 PX pilot program rollout, patients elected online registration more than twice as often as expected, a testament to the growing demand for modern, digital solutions for healthcare. On the healthcare provider side, pilot results also found that physicians booked up to 40% of their patients’ appointments online.

“We look to drive the revenue cycle transformation in this next era of healthcare through the development of platforms and technologies like R1 PX,” said Jack Brock, EVP of Product and Technology for R1. “Our solutions empower patients to take charge of their healthcare and offer an improved experience—freeing up providers to focus on delivering the highest quality care.”

Gary Long, EVP, Chief Commercial Officer, “We focus on solving our clients’ key challenges across the revenue cycle. Many progressive organizations have put the patient and their experience at the center of that strategy.” Mr. Long continued, “After a thorough pilot showing demonstrable results supporting this endeavor we are excited to launch this integrated capability.”

R1 RCM will debut its Patient Experience (PX) solution at the HIMSS18 Conference, March 6-8, Booth #10715, where conference attendees can see and learn more about R1 PX.

About R1 RCM
R1 is a leading provider of technology-enabled revenue cycle management services which transform a health system’s revenue cycle performance across settings of care. R1’s proven and scalable operating model, the R1 Performance Stack℠, seamlessly complements a healthcare organization’s infrastructure, quickly driving sustainable improvements to net patient revenue and cash flows while reducing operating costs and enhancing the patient-experience. To learn more visit:

Forward Looking Statements
This press release includes statements that may constitute “forward-looking statements” made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In particular, statements about future events and relationships, plans, and future growth, are forward-looking statements. These statements are often identified by the use of words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “designed,” “may,” “plan,” “predict,” “project,” “would” and similar expressions or variations, although not all forward-looking statements contain these identifying words. The Company has based these forward-looking statements on its current expectations and projections about future events as of the date hereof and any forward-looking statements contained herein should not be relied upon as representing the Company’s views as of any subsequent date. Subsequent events and developments, including actual results or changes in our assumptions, may cause our views to change. While the Company may elect to update these forward-looking statements at some point in the future, it has no current intention of doing so except to the extent required by applicable law. Although the Company believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected. Should one or more of these risks and uncertainties materialize, or should underlying assumptions, projections, or expectations prove incorrect, actual results, performance, financial condition, or events may vary materially and adversely from those anticipated, estimated, or expected.

Investors are cautioned not to place undue reliance on such forward-looking statements. Any forward-looking statements made herein involve risks and uncertainties. All forward-looking statements included in this press release are expressly qualified in their entirety by these cautionary statements. Our actual results and outcomes could differ materially from those included in these forward-looking statements as a result of various factors, including, but not limited to, the factors discussed under the heading “Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2016, and any other periodic reports that the Company files with the SEC.

R1 RCM Inc.
Investor Relations:
Atif Rahim

Media Relations:
Natalie Joslin


Last updated on: 05/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.